100 related articles for article (PubMed ID: 19166957)
1. Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model.
Kagan L; Lavy E; Hoffman A
Pulm Pharmacol Ther; 2009 Jun; 22(3):260-5. PubMed ID: 19166957
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms.
Albrecht H; Vernon M; Solomon G
Respir Res; 2012 Dec; 13(1):118. PubMed ID: 23270519
[TBL] [Abstract][Full Text] [Related]
3. Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection.
Tripathi S; Nikhare A; Sharma G; Shea T; Albrecht H
Drug Healthc Patient Saf; 2019; 11():87-94. PubMed ID: 31632154
[TBL] [Abstract][Full Text] [Related]
4. Guaifenesin: The Ubiquitous Orphan.
Eyassu DG; McCoul ED
Otolaryngol Head Neck Surg; 2024 May; ():. PubMed ID: 38804670
[TBL] [Abstract][Full Text] [Related]
5. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells.
Seagrave J; Albrecht H; Park YS; Rubin B; Solomon G; Kim KC
Exp Lung Res; 2011 Dec; 37(10):606-14. PubMed ID: 22044398
[TBL] [Abstract][Full Text] [Related]
6. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment.
Kuhn JJ; Hendley JO; Adams KF; Clark JW; Gwaltney JM
Chest; 1982 Dec; 82(6):713-8. PubMed ID: 6754274
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of paracetamol, phenylephrine hydrochloride and guaifenesin in a fixed-combination syrup versus an oral reference product.
Janin A; Monnet J
J Int Med Res; 2014 Apr; 42(2):347-59. PubMed ID: 24553480
[TBL] [Abstract][Full Text] [Related]
8. Guaifenesin Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years.
Thompson GA; Solomon G; Albrecht HH; Reitberg DP; Guenin E
J Clin Pharmacol; 2016 Jul; 56(7):894-901. PubMed ID: 26632082
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of guaifenesin following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Benson D; Arthur RM
J Vet Pharmacol Ther; 2016 Aug; 39(4):416-9. PubMed ID: 26763117
[TBL] [Abstract][Full Text] [Related]
10. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers.
Sisson JH; Yonkers AJ; Waldman RH
Chest; 1995 Mar; 107(3):747-51. PubMed ID: 7874947
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys.
Matthews NS; Peck KE; Mealey KL; Taylor TS; Ray AC
J Vet Pharmacol Ther; 1997 Dec; 20(6):442-6. PubMed ID: 9430767
[TBL] [Abstract][Full Text] [Related]
12. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.
Seagrave J; Albrecht HH; Hill DB; Rogers DF; Solomon G
Respir Res; 2012 Oct; 13(1):98. PubMed ID: 23113953
[TBL] [Abstract][Full Text] [Related]
13. Postmortem distribution of guaifenesin concentrations reveals a lack of potential for redistribution.
McIntyre IM; Navarrete A; Mena O
Forensic Sci Int; 2014 Dec; 245():87-91. PubMed ID: 25447180
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers.
Gelotte CK; Zimmerman BA
Clin Drug Investig; 2015 Sep; 35(9):547-58. PubMed ID: 26267590
[TBL] [Abstract][Full Text] [Related]
15. Swift onset of central nervous system depression and asystole followingan overdose of Guaifenesin.
Okic M; Johnson T; Crifasi JA; Long C; Mitchell EK
J Anal Toxicol; 2013 Jun; 37(5):318-9. PubMed ID: 23580607
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral decongestants.
Kanfer I; Dowse R; Vuma V
Pharmacotherapy; 1993; 13(6 Pt 2):116S-128S; discussion 143S-146S. PubMed ID: 7507589
[TBL] [Abstract][Full Text] [Related]
17. The effect of guaiphenesin on absorption and bioavailability of paracetamol from composite analgesic preparations.
Perlík F; Janku I; Kordac V
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):413-6. PubMed ID: 3220616
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse.
Rumpler MJ; Colahan P; Sams RA
J Vet Pharmacol Ther; 2014 Feb; 37(1):25-34. PubMed ID: 23859819
[TBL] [Abstract][Full Text] [Related]
19. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
Albrecht HH; Dicpinigaitis PV; Guenin EP
Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
